WuXi Biologics

2025.08.04

09:47

Hong Kong-listed pharmaceutical stocks fluctuated lower, with China Resources Medical falling over 13%.

Hong Kong-listed pharmaceutical stocks fluctuated downward, with China Resources Medical falling more than 13%, while Shijiazhuang Pharmaceutical Group, Fosun Pharma, MicroPort Medical, WuXi AppTec, and WuXi Biologics all fell more than 3%.

2025.07.29

11:06

The Hong Kong stock market's biopharmaceutical sector continued to strengthen, with WuXi AppTec (02359.HK) rising by more than 10%, Tiger Pharmaceuticals (03347.HK) rising by more than 5%, and Fuhong Hanlin (02696.HK) and WuXi Biologics (02269.HK) following suit.

2025.07.25

17:49

Southbound funds net bought HK$20.184 billion today, and the Hang Seng Index Fund received a net purchase of HK$7.28 billion.

Southbound funds net bought HK$20.184 billion today. Among them, Tracker Fund Management, Hang Seng China Enterprises and China Life ranked the top three in terms of net buying, with net buying of HK$7.28 billion, HK$1.435 billion and HK$955 million respectively; in terms of net selling, Kuaishou-W, WuXi Biologics and Guotai Junan International were net sold HK$667 million, HK$198 million and HK$117 million respectively.

12:03

Hong Kong Stock Midday Review: Hang Seng Index fell 1.11%, Hang Seng Technology Index fell 1.69%

As of midday close, the Hang Seng Index fell 1.11% and the Hang Seng Technology Index fell 1.69%. On the market, online education stocks, film and television stocks, lithium batteries, and rare earth permanent magnets led the decline, while pharmaceutical outsourcing concepts, logistics, chips, semiconductors, and domestic real estate stocks led the gains. In terms of individual stocks, Kuaishou, Bilibili, and Huanxi Media fell more than 4%, New Oriental fell more than 2%, and BYD shares fell more than 2%; Shuntai Holdings rose more than 10%, Kanglong Chemical rose more than 8%, WuXi Biologics rose more than 4%, Nongfu Spring rose more than 3%, and JD Logistics rose more than 2%.

09:45

Hong Kong stocks CXO concept stocks rose in early trading, Kanglong Chemical rose more than 10%

Hong Kong-listed CXO concept stocks rose in early trading, with Corning Life Sciences rising more than 10%, Zhaoyan Pharmaceutical rising more than 6%, WuXi Biologics rising more than 4%, and Tiger Pharmaceuticals and WuXi AppTec following suit.

2025.07.24

13:09

Hong Kong-listed pharmaceutical stocks continued to rise in the afternoon, with MicroPort Medical rising more than 16%.

Hong Kong-listed pharmaceutical stocks continued to rise in the afternoon, with MicroPort Medical rising more than 16%, 3SBio rising more than 8%, WuXi Biologics rising 4%, and China Resources Medical, WuXi AppTec, and Fosun Pharma all rising.

2025.07.23

09:53

Hong Kong-listed biopharmaceutical stocks rose collectively, with WuXi Biologics (02268.HK) rising more than 12%, WuXi Biologics (02269.HK) rising more than 4%, BeiGene (06160.HK) and Tiger Pharmaceuticals (03347.HK) rising more than 3%.

09:39

Hong Kong stocks CXO concept stocks rose in early trading, with Frontage Holdings rising more than 23%

Hong Kong-listed CXO concept stocks rose in early trading, with Frontage Holdings rising more than 23%, Corning Life Sciences and CStone Pharmaceuticals rising more than 4%, and WuXi Biologics, WuXi AppTec and Tiger Pharmaceuticals all rising.

2025.07.11

12:01

Hong Kong Stock Midday Review: Hang Seng Index rose 1.90% and Hang Seng Technology Index rose 2.08%

At the close of Hong Kong stocks at noon, the Hang Seng Index rose 1.90%, and the Hang Seng Technology Index rose 2.08%. The Hong Kong Stock Technology ETF (159751) rose 1.17%, and the Hang Seng Hong Kong Stock Connect ETF (159318) rose 1.22%. WuXi AppTec rose more than 11%, NIO rose more than 7%, WuXi Biologics rose more than 6%, and Ping An of China rose more than 5%.

09:35

Hong Kong stocks CXO concept stocks rose in early trading, and Kaleo rose more than 10%

Hong Kong-listed CXO concept stocks rose in early trading, with CStone Pharmaceuticals up more than 10%, WuXi AppTec up more than 9%, Zhaoyan Pharmaceutical up more than 7%, Corning Life Sciences and WuXi Biologics up more than 4%.

2025.07.07

11:27

Hong Kong stocks CXO concept stocks fluctuated downward, WuXi Biologics fell more than 5%

CXO concept stocks in Hong Kong stocks fluctuated downward, with WuXi Biologics falling more than 5%, GenScript Biotech falling more than 3%, and CStone Pharmaceuticals, WuXi AppTec, Tigermed, and Zhaoyan Pharmaceutical falling more than 2%.

10:14

Hong Kong stocks with biopharmaceutical concepts led the decline in early trading, with Rongchang Biopharma (09995.HK) falling more than 5%, WuXi Biologics (02268.HK) and WuXi Biologics (02269.HK) both falling more than 4%, and InnoCare Pharma (09969.HK), WuXi AppTec (02359.HK) and other stocks following the decline; on the news front, the U.S. "Big Beautiful Act" was passed early this morning, the bill proposes to cut healthcare spending.

2025.06.16

16:10

Hong Kong stocks closed: Hang Seng Index rose 0.70% Hang Seng Technology Index rose 1.15%

At the close of Hong Kong stocks, the Hang Seng Index rose 0.70%, and the Hang Seng Technology Index rose 1.15%. The Hong Kong Stock Technology ETF (159751) closed up 0.78%, and the Hang Seng Hong Kong Stock Connect ETF (159318) closed up 0.77%. Shandong Molong rose more than 30%, ZhongAn Online rose more than 12%, and Xiaomi Group rose more than 4%; WuXi Biologics fell more than 5%.

12:01

Hong Kong Stocks Midday Review: Hang Seng Index fell 0.12% Hang Seng Technology Index rose 0.15%

At the close of Hong Kong stocks at noon, the Hang Seng Index fell 0.12%, and the Hang Seng Technology Index rose 0.15%. Oil and gas stocks and domestic real estate stocks led the gains, with Shandong Molong rising more than 30%, ZhongAn Online and R&F Properties rising nearly 10%, and WuXi Biologics falling more than 6%.

09:23

Hong Kong stocks opened, the Hang Seng Index opened down 0.42%, the Sci-Tech Index opened down 0.61%. WuXi Biologics (02269.HK) fell 3.57% as the company's major shareholder placed existing shares.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Novo Nordisk (NVO.N): The downward revision of its fiscal year sales forecast is related to declining sales of its weight loss drug Wegovy in the United States.
                            2025-07-29

                                    Toyota Motor Corp. is expected to decide as early as Wednesday evening whether to resume operations at its Japanese factories.
                            2025-07-30

                                    CATL's losses widened in the afternoon, with A shares falling more than 4% to below 280 yuan and H shares falling more than 7%.
                            2025-07-30

                                    BYD: Sales of new energy vehicles in July were 344,296 units. The cumulative sales of new energy vehicles from January to July were 2,490,250 units, a year-on-year increase of 27.35%.
                            2025-08-01

                                    Amazon (AMZN.O) shares plummeted 7.1 percent, wiping out $178 billion in market value.
                            2025-08-01